| Financial Year |
March 31 2023 |
| Monetary Funds |
191,903,602.68 |
| Held-for-trading Financial Assets |
130,000,000.00 |
| Notes Receivable |
8,153,700.68 |
| Accounts Receivable |
44,462,340.92 |
| Advances to Suppliers |
3,580,098.67 |
| Other Receivables |
2,548,562.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
330,955,885.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,146,067.86 |
| Total Current Assets |
750,170,035.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
366,418,195.29 |
| Under-construction Projects |
14,091,879.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
106,183,466.40 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
486,703,541.59 |
| Total Assets |
1,236,873,576.69 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,000,000.00 |
| Accounts Payable |
104,966,016.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,529,162.51 |
| Taxes Payable |
4,765,641.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,188,513.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
2,849,956.87 |
| Sub-Total of Current Liabilities |
159,446,329.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,346,633.08 |
| Deferred Income Tax Liabilities |
6,800,632.72 |
| Other Non-Current Liabilities |
32,502,769.50 |
| Sub-Total of Non-Current Liabilities |
47,867,755.30 |
| Total Liabilities |
207,314,084.99 |
| Paid-In Capital(Or Share Stock) |
163,191,700.00 |
| Capital Surplus |
356,630,217.17 |
| Surplus Reserve |
58,753,788.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
450,983,786.48 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,029,559,491.70 |
| Owner's Equity（Stockholder's Equity） |
1,029,559,491.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,236,873,576.69 |
